Creating a Canadian Indigenous Research Network Against Cancer to Address Indigenous Cancer Disparities.


Journal

JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 29 7 2021
Statut: ppublish

Résumé

In Canada, indigenous peoples' cancer rates have increased, but cancer screening rates tend to be lower. When coupled with poor cancer prognosis, treatment barriers, and inaccessible health care, indigenous patients with cancer experience many unmet needs. Further complicating their journey is a multijurisdictional system that complicates cancer control services, treatments, patient supports, and cancer surveillance. To address these issues, the Canadian Indigenous Research Network Against Cancer (CIRNAC) was developed. This article describes the forerunners and consultative process that created the network and the consensus model developed to ground this network with, by, and for indigenous peoples. A consultative workshop was held to (1) establish and increase network membership, (2) enhance partnerships with indigenous communities and other researchers, and (3) develop an indigenous-led research program, new funding, and related initiatives. Participants viewed the CIRNAC as a reflective parallel network led by indigenous peoples that would identify research priorities within Canada, assess how these priorities align with indigenous patients' cancer care and research needs, and cross-check to see if these priorities align with each other. The network would also advocate for indigenous elders/knowledge holders and community grassroot processes to drive research and training, thus demonstrating the power of the community voice and lived experience in research. In addition, the network would foster research partnerships to investigate alternative indigenous models for cancer prevention, care, treatment, and support. The CIRNAC evolved as a viable vehicle to address cancer with, for, and by indigenous peoples. The network is guided by a preamble, a set of aims, and an inclusion engagement circle model. It is evolving through major world initiatives, with the aim of formally becoming an internationally linked national network.

Identifiants

pubmed: 32031447
doi: 10.1200/JGO.19.00049
pmc: PMC6998023
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-98

Subventions

Organisme : CIHR
Pays : Canada

Références

J Rural Health. 2014 Summer;30(3):311-21
pubmed: 24483272
CMAJ. 2018 Mar 19;190(11):E320-E326
pubmed: 29555862
Lancet Oncol. 2015 Nov;16(15):1442-1444
pubmed: 26476759
Lancet. 2018 Apr 28;391(10131):1645-1648
pubmed: 29483024
Health Promot Chronic Dis Prev Can. 2017 Jun;37(6):186-193
pubmed: 28614046
Int J Gen Med. 2011;4:699-709
pubmed: 22069372
Can J Public Health. 2018 Dec;109(5-6):700-709
pubmed: 29981110
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):145-151
pubmed: 27965294
Ann Epidemiol. 2018 May;28(5):335-342
pubmed: 29503062
Lancet Oncol. 2015 Nov;16(15):1483-1492
pubmed: 26476758
Nurs Inq. 2009 Dec;16(4):306-17
pubmed: 19906281
Soc Sci Med. 2015 Aug;138:179-86
pubmed: 26112164

Auteurs

Angeline Letendre (A)

Alberta Health Services, Edmonton, Alberta, Canada.

Gail Garvey (G)

Menzies School of Health Research, Brisbane, Queensland, Australia.

Alexandra King (A)

University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Malcolm King (M)

University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Reg Crowshoe (R)

Piikani First Nation, Alberta, Canada.

Lea Bill (L)

Alberta First Nation Information Governance Centre, Calgary, Alberta, Canada.

Nadine R Caron (NR)

University of British Columbia, Vancouver, British Columbia, Canada.

Brenda Elias (B)

University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH